Deficient nonhomologous end-joining activity in cell-free extracts from Brca1-null fibroblasts
- PMID: 12124328
Deficient nonhomologous end-joining activity in cell-free extracts from Brca1-null fibroblasts
Abstract
BRCA1 ensures genomic stability, at least in part, through a functional role in DNA damage repair. BRCA1 interacts with the Rad50/Mre11/Nbs1 complex that occupies a central role in DNA double-strand break repair mediated by homologous recombination and nonhomologous end joining (NHEJ). NHEJ can be catalyzed by mammalian whole cell extract in a reaction dependent upon DNA ligase IV, Xrcc4, Ku70, Ku80, and DNA-PKcs. Here, we show that under identical cell-free reaction conditions, the addition of antibodies specific for BRCA1 and Rad 50 but not Rad51, inhibits end-joining activity. Cell extracts derived from Brca1-deficient mouse embryonic fibroblasts exhibit reduced end-joining activity independent of the endogenous protein amounts of DNA ligase IV, Ku80, and Ku70. The Brca1-dependent NHEJ activity predominates at the lower concentrations of Mg2+ (0.5 mM); elevated Mg2+ or Mn2+ concentrations (10 mM) dramatically increase overall end-joining activity and abrogates the requirement for Brca1, Xrcc4, and Ku70. The addition of partially purified BRCA1, in association with Rad50/Mre11/Nbs1 complex, complements the NHEJ deficiency of Brca1-null fibroblast extracts. These results suggest a role for Brca1 in NHEJ and in the maintenance of genome integrity.
Similar articles
-
Breast cancer risk and the DNA double-strand break end-joining capacity of nonhomologous end-joining genes are affected by BRCA1.Cancer Res. 2004 Jul 15;64(14):5013-9. doi: 10.1158/0008-5472.CAN-04-0403. Cancer Res. 2004. PMID: 15256476
-
Non-homologous end joining is the responsible pathway for the repair of fludarabine-induced DNA double strand breaks in mammalian cells.Mutat Res. 2008 Nov 10;646(1-2):8-16. doi: 10.1016/j.mrfmmm.2008.08.013. Epub 2008 Sep 4. Mutat Res. 2008. PMID: 18812179
-
The role of the BRCA1 tumor suppressor in DNA double-strand break repair.Mol Cancer Res. 2005 Oct;3(10):531-9. doi: 10.1158/1541-7786.MCR-05-0192. Mol Cancer Res. 2005. PMID: 16254187 Review.
-
Identification of genes involved in repair of DNA double-strand breaks in mammalian cells.Radiat Res. 1998 Nov;150(5 Suppl):S80-91. Radiat Res. 1998. PMID: 9806611 Review.
-
Checkpoint kinase 2-mediated phosphorylation of BRCA1 regulates the fidelity of nonhomologous end-joining.Cancer Res. 2006 Feb 1;66(3):1401-8. doi: 10.1158/0008-5472.CAN-05-3278. Cancer Res. 2006. PMID: 16452195
Cited by
-
BRCA1 and BRCA2: different roles in a common pathway of genome protection.Nat Rev Cancer. 2011 Dec 23;12(1):68-78. doi: 10.1038/nrc3181. Nat Rev Cancer. 2011. PMID: 22193408 Free PMC article. Review.
-
Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brca1 full-length isoform.Genes Dev. 2003 Jan 15;17(2):201-13. doi: 10.1101/gad.1050003. Genes Dev. 2003. PMID: 12533509 Free PMC article.
-
Loss of homologous recombination or non-homologous end-joining leads to radial formation following DNA interstrand crosslink damage.Cytogenet Genome Res. 2008;121(3-4):174-80. doi: 10.1159/000138882. Epub 2008 Aug 28. Cytogenet Genome Res. 2008. PMID: 18758156 Free PMC article.
-
Polyploid cells rewire DNA damage response networks to overcome replication stress-induced barriers for tumour progression.Nat Commun. 2012 May 8;3:815. doi: 10.1038/ncomms1825. Nat Commun. 2012. PMID: 22569363 Free PMC article.
-
BRCA1 and p53: compensatory roles in DNA repair.J Mol Med (Berl). 2003 Nov;81(11):700-7. doi: 10.1007/s00109-003-0477-0. Epub 2003 Sep 9. J Mol Med (Berl). 2003. PMID: 13679996 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous